Oruka Therapeutics (ORKA) Total Non-Current Liabilities (2014 - 2025)
Oruka Therapeutics' (ORKA) quarterly Total Non-Current Liabilities came in at $12.8 million in Q3 2025, up 14.07% year-on-year from $11.2 million in Q3 2024, and up 19.55% quarter-over-quarter from $10.7 million in Q2 2025.
Oruka Therapeutics (ORKA) Total Non-Current Liabilities (2014 - 2025) Analysis & Trends
Oruka Therapeutics' Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $12.8 million for Q3 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 14.07% year-over-year to $12.8 million in Q3 2025; TTM through Sep 2025 was $12.8 million, a 14.07% increase from a year earlier, with the FY2015 full-year figure at $1.5 million, up 8.12% from the prior year.
- Total Non-Current Liabilities climbed to $12.8 million in Q3 2025 per ORKA's latest filing, from $10.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $12.8 million in Q3 2025 and bottomed at $784000.0 in Q3 2023.
- The 3-year median for Total Non-Current Liabilities is $10.8 million (2025), against an average of $8.0 million.
- Across the five-year window, Total Non-Current Liabilities surged 1328.57% in 2024 and climbed 14.07% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $784000.0 in 2023, then jumped by 1328.57% to $11.2 million in 2024, then gained by 14.07% to $12.8 million in 2025.
- Per Business Quant, the three latest ORKA Total Non-Current Liabilities figures stand at $12.8 million (Q3 2025), $10.7 million (Q2 2025), and $11.0 million (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.28 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.98 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 949,738.67 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 746.94 Mn |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.78 Mn |
| Jun 30, 2025 | 10.69 Mn |
| Mar 31, 2025 | 10.97 Mn |
| Sep 30, 2024 | 11.20 Mn |
| Sep 30, 2023 | 784,000.00 |
| Jun 30, 2023 | 1.41 Mn |
| Dec 31, 2015 | 1.50 Mn |
| Dec 31, 2014 | 1.39 Mn |